Skip to content

AptarGroup ATR Enterprise value

Enterprise value at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$17.87B+11.1%
Amcor logo
AmcorAMCR
$32.92B+55.2%
Nordson logo
NordsonNDSN
$17.96B+38.4%
Baxter International logo
Baxter InternationalBAX
$6.88B-55.6%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$9.52B+3.0%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$10B+71.5%

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Calculated from AptarGroup’s reported figures.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's enterprise value?
AptarGroup (ATR) reported enterprise value of $9.25B in Q1 2026.
How has AptarGroup's enterprise value changed year-over-year?
AptarGroup's enterprise value decreased by 13.9% year-over-year, from $10.74B to $9.25B.
What is the long-term trend for AptarGroup's enterprise value?
Over 5 years (2020 to 2025), AptarGroup's enterprise value has grown at a -1.7% compound annual growth rate (CAGR), from $9.98B to $9.17B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.